As global markets rebound and technology stocks lead the charge, investors are keenly watching high-growth sectors for potential opportunities. With the S&P 500 Index recovering from recent losses and ...

Over the last 7 days, the market has dropped 3.4%, but over the longer term, it has risen by 20% in the last year with earnings forecasted to grow by 15% annually. In this dynamic environment, ...

It is also developing ex vivo applications to address immuno-oncology and autoimmune diseases. Latest Biotechnology & Medical Research and TG Therapeutics Inc, Intellia Therapeutics Inc Stock News As ...

The BTK inhibitors market has experienced significant dynamics driven by advancements in oncology and autoimmune disease ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the United States Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to investigational plozasiran as ...

TG Therapeutics shares made new 52-week highs this week, helped in part by new Briumvi data presentations at ECTRIMS. Find ...

During the last three months, 4 analysts shared their evaluations of TG Therapeutics TGTX, revealing diverse outlooks from ...

Most readers would already be aware that TG Therapeutics' (NASDAQ:TGTX) stock increased significantly by 49% over the past three months. Since the market usually pay for a company’s long-term ...